## VRSK: Verisk Analytics, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -0.0% below STRENGTH zone (3.0-6.0%); PEG 2.78 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($212.54)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Railway Pension Investments Ltd Increases Stake in Verisk Analytics, Inc. $VRSK**
- Source: MarketBeat | 20260105T123016 | Somewhat-Bullish | Relevance: 100%
- Railway Pension Investments Ltd significantly increased its stake in Verisk Analytics, Inc. (NASDAQ:VRSK) by 24.0% in Q3, adding 11,900 shares and bringing its total holdings to 61,400 shares valued at $15.443 million. Institutional investors now own approximately 90.0% of VRSK, with corporate insiders holding a much smaller 0.46%. Verisk reported Q3 EPS of $1.72, beating estimates, and offered FY2025 EPS guidance, while analysts currently rate the stock as a "Hold" with an average price target of $278.64.

**2. Verisk Ends Effort to Acquire AccuLynx**
- Source: citybiz | 20260104T130822 | Somewhat-Bearish | Relevance: 100%
- Verisk (Nasdaq: VRSK) announced the termination of its agreement to acquire AccuLynx following notification from the Federal Trade Commission (FTC) that its review of the transaction had not been completed by the stipulated December 26, 2025 termination date. Verisk will redeem $1.50 billion in senior notes issued for the planned acquisition and strongly disagrees with AccuLynx's assertion that the termination is invalid. Verisk's CEO, Lee Shavel, reaffirmed the company's commitment to capital allocation discipline and achieving long-term growth targets.

**3. Precision Trading with Verisk Analytics Inc. (VRSK) Risk Zones**
- Source: Stock Traders Daily | 20260103T212400 | Somewhat-Bearish | Relevance: 100%
- This article provides a detailed analysis of Verisk Analytics Inc. (VRSK), highlighting a potential shift in near-term sentiment and a mid-channel oscillation pattern. It presents three distinct AI-generated trading strategies tailored for different risk profiles, along with multi-timeframe signal analysis, to assist traders in optimizing position sizing and managing risk. The analysis indicates an exceptional short setup targeting 11.6% downside versus 0.3% risk.

**4. JARISLOWSKY FRASER Ltd Sells 11,369 Shares of Verisk Analytics, Inc. $VRSK**
- Source: MarketBeat | 20260103T144328 | Neutral | Relevance: 100%
- JARISLOWSKY FRASER Ltd reduced its stake in Verisk Analytics, Inc. by selling 11,369 shares, bringing its total ownership to 86,669 shares valued at approximately $21.8 million. This transaction occurred as other institutional investors made significant moves in VRSK, and Verisk reported Q3 EPS of $1.72, exceeding estimates, with revenue up 5.9% year-over-year. Analysts currently hold a "Hold" consensus rating with a target price of $278.64 for the company.

**5. 1 Cash-Producing Stock with Solid Fundamentals and 2 That Underwhelm**
- Source: Finviz | 20260104T234100 | Somewhat-Bearish | Relevance: 83%
- This article analyzes three companies based on their cash flow and shareholder value creation. It recommends "selling" UFP Industries (UFPI) and Verisk (VRSK) due to declining sales, profitability issues, and slow growth compared to peers for the former, and slow revenue and EPS growth for the latter. Conversely, Accenture (ACN) is highlighted as a "stock to watch" because of its strong revenue growth, substantial market presence, and high return on capital.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $270 | $290 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.31M) |
| Sells | 5 ($0.68M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (+2.0%)
- Blackrock Inc.: 9.4% (+5.5%)
- State Street Corpora: 4.3% (-1.3%)
- Alliancebernstein L.: 3.8% (+3.1%)
- FMR, LLC: 3.1% (-22.9%)

### Key Risks

1. Long-term trend broken: trading 17.6% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.78 signals overvaluation risk, limited margin of safety. Forward P/E 28.8x stretched relative to 10% growth. Quality metrics strong (ROE 268%, ROA 16%, margin 30%). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $30.8B |
| Beta | 0.81 |
| 52W Range | $197.00 - $322.92 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.78 |
| Forward P/E | 28.8 |
| Current P/E | 31.8 |
| YoY Growth | 10.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.6% to -0.0% (-1.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.0pp (needs >3.0% for momentum thesis). Below SMA200 (0.82x), long-term trend not supportive. MACD histogram positive (0.58), confirming momentum. RSI neutral at 49. OFD pattern: +DUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.04% (CS: 40) | Neutral |
| RSI_14 | 49.2 | Neutral |
| MACD Histogram | 0.58 | Bullish |
| vs SMA20 | 1.006x | Above |
| vs SMA50 | 1.001x | Above |
| vs SMA200 | 0.824x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $220.70
- **Stop Loss:** $212.54 (3.7% risk)
- **Target:** $228.86 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 169
- **Position Value:** $37,298.30
- **Portfolio %:** 37.30%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-25 (Est: $1.61)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.70 | $1.72 | +1.0% |
| 2025Q2 | $1.77 | $1.88 | +6.1% |
| 2025Q1 | $1.68 | $1.73 | +2.8% |
| 2024Q4 | $1.60 | $1.61 | +0.8% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_10*